Search results

64 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
New SARS-like virus can jump directly from bats to humans, no treatment available
Findings provide an opportunity to develop drugs and vaccines for coronaviruses before they emerge from animals to cause a human epidemic
Located in News / 2015 / November
From Liberia to Chapel Hill: Compassionate Care and a Taste of Home
When David Wohl, MD, met Patience Wesseh in Liberia, her face was badly scarred by a burn injury, and he knew he could help. Since April when she arrived in Chapel Hill to begin her treatment at the North Carolina Jaycee Burn Center, Patience has brought her own unique flavor to Wohl’s home.
Located in News / 2015 / December
Corbett continues quest for dengue fever vaccine
In this new series, we profile graduate students who conduct research in labs across the UNC School of Medicine. First up is Kizzmekia Corbett, who received an off-campus dissertation fellowship from the UNC Graduate School to travel to Sri Lanka. Corbett will collect blood samples to search for a specific antibody response to the dengue virus, a key step in creating a vaccine for the world's most widespread mosquito-borne disease.
Located in News / 2014 / February
UNC researchers discover new target for dengue virus vaccine
By re-engineering a tiny chain of amino acids in one type of dengue virus, Ralph Baric and Aravinda de Silva discover a new path toward solving the dengue vaccine dilemma. The research has the potential to transform vaccine development for other diseases, including SARS and HIV.
Located in News / 2014 / February
UNC receives more than $40 million from NIH for global clinical trials unit to treat and prevent HIV
The University of North Carolina at Chapel Hill has received a seven-year, more than $40 million award from the National Institutes of Health for a clinical trials unit that will implement the scientific agendas of five NIH networks devoted to HIV/AIDS treatment, prevention, and cure research.
Located in News / 2014 / February
Dispatch from Guinea: Containing Ebola
UNC’s Dr. William Fischer II has been working in an isolation area in Gueckedou, Guinea, since May 28, 2014, as part of a team from Doctors without Borders (Médecins Sans Frontières/MSF) to try to help reduce mortality from Ebola Virus in rural communities. Dr. Fischer was recruited by the World Health Organization (WHO) because of his critical care medicine expertise. With Dr. Fischer’s permission, we are posting his descriptive emails, that give insight into the experience of a frontline effort to contain the deadly pathogen.
Located in News / 2014 / June
UNC receives $8 million grant to improve safe motherhood in Malawi
The University of North Carolina at Chapel Hill has received a five-year, $8 million grant from the Bill & Melinda Gates Foundation to improve maternal and infant health and save the lives of mothers and infants in Malawi by strengthening the President’s Maternal Health and Safe Motherhood Initiative (SMI).
Located in News / 2013 / July
Dr. Anthony Charles meets President Clinton in Malawi
Members of the UNC Malawi Surgical Initiative meet with former President Bill Clinton about surgical and burn care.
Located in News / 2013 / August
UNC-Malawi cancer pathology laboratory is a model for Sub-Saharan Africa
The laboratory has provided an invaluable service to patients and has also built capacity at a national teaching hospital, according to an analysis of the first 20 months of operation published online by PLOS ONE.
Located in News / 2013 / August
UNC, Duke Team up with Carrboro-based Caktus Group on HIV Gaming App
The Daily Dose app will utilize game mechanics and social networking features to improve adherence to HIV medication.
Located in News / 2013 / October